Fusix Biotech
PrivateLast Round
Grant
Dec 13, 2023
Total Funding Raised
$1.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fusix Biotech operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Grant round in December 2023.
Fusix Biotech is a biotechnology company that is a developer of a cancer therapy designed for commercializing a novel fusion-based oncolytic viro-immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fusix Biotech Comparables
Compare Fusix Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theolytics | 79% | |
| Circio Holding ASA | 76% | |
| Lokon Pharma | 76% |
For institutional investors. Book with your work email.
Fusix Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 13, 2023 | ||||
| Grant | Sep 27, 2023 | ||||
| Pre Seed | Jul 1, 2022 |
For institutional investors. Book with your work email.
Fusix Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlueYard Capital | Grant |
| Bavarian State Ministry of Economic Affairs, Regional Development and Energy | Pre Seed |
| Nucleate | Grant |
| BioM AG Munich BioTech Development | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 364% MoM, from 90 to 418.
- May 19, 2026
Monthly visitors increased 145% MoM.
For institutional investors. Book with your work email.
Fusix Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fusix Biotech's valuation, stock price, and market status.
Is Fusix Biotech a public or private company?
Fusix Biotech is a private company.
What is the current stock price of Fusix Biotech?
Fusix Biotech is a private company, so its shares have no public market price. Caplight tracks Fusix Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fusix Biotech worth (valuation)?
Valuation information for Fusix Biotech is not publicly available.
Can I buy Fusix Biotech stock?
Fusix Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fusix Biotech's last funding round?
Fusix Biotech's most recent funding round was Grant on December 13, 2023.
Who are the main investors in Fusix Biotech?
Key investors in Fusix Biotech include BlueYard Capital.
Will Fusix Biotech IPO soon?
No public IPO plans have been announced for Fusix Biotech.
How can I track Fusix Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Fusix Biotech's shares on secondary markets.